Patient P-01577
Therapy response
Improving
Tolerance
Favorable
GI state
Favorable
Inflammatory state
Favorable
Nutritional resilience
Favorable
Discontinuation risk
12%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 NBL-101 started — Baseline state S20
- Day 88 HY-01 recommended — Hydration Protocol HY-01
- Day 89 Patient accepted — Started HY-01 in the companion
- Day 93 No meaningful change — Hydration Protocol HY-01
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- Inflammatory activity-2
- Treatment adherence+2
What helped?
- Hydration Protocol HY-01Day 88Result: no meaningful change
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
GI burden
Companion17.8/100
worsening · +8.1 vs previous 14 d
Toxicity
Blood20.9/100
worsening · +1.2 vs previous 14 d
Sleep quality
Wearable25.4/100
worsening · -3.5 vs previous 14 d
Energy level
Daily log6.3/10
worsening · -0.3 vs previous 14 d
Stress level
Daily log4.8/10
stable · +0.1 vs previous 14 d
Steps
Wearable8,240
stable · -269 vs previous 14 d
Adherence
Companion96.8 %
stable · -2.9 vs previous 14 d
This trajectory is doing well — what to keep, what to watch
Steering view →Heading towards restoration · 83 from the failing basin, 5 from restoration.
Good elements to keep
- Hydration Protocol HY-01intervention · steering +8.5
- Butyrate producers intacthidden · steering +7.5
- Daily walks resumedperturbation · steering +3.3
Main detractors to watch
- Poor metabolizerhidden · steering -12.7
- Alcoholperturbation · steering -7.2
- Dietary fat loadperturbation · steering -3.8
- Poor-sleep weekperturbation · steering -3
- Alcoholdetractor · GI +3.9 next day
- Dietary fat loaddetractor · GI +2.5 next day
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Alcohol+3.9detractor · 95%
- Dietary fat load+2.5detractor · 66%
- Simple carbohydrates-0.8no signal · 17%
- Insoluble fibre+0.8no signal · 21%
- Histamine load+0.5no signal · 15%
- Spicy / capsaicin-0.3no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Drug metabolism and exposure ↑40
- DNACYP2D6 poor metabolizer → higher exposure
- Autonomic recovery ↓20
- WearableShort sleep window
- Mucosal barrier integrity ↓10
- WearableSleep 5.3 h, below personal baseline
DNA
Fictional pharmacogenomic panel
- CYP2D6 Poor metabolizerHigher exposure at standard dose
Microbiome
Shannon diversity 3.4 · butyrate capacity 63/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisNormal
- Bifidobacterium longumNormal
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 40 ms
- Sleep
- 6.3 h
- Steps
- 8,791
- Resting HR
- 63 bpm
Daily log: GI score 18, nutritional resilience 65, adherence 97.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Protect a 7.5-hour sleep window; screens off 30 minutes before
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.